Allan Jordan

Views & Analysis

We speak to R&D experts to find out how oncology biotechs can get the support they need to be successful in the competitive UK ecosystem

News

Sanofi's neurology pipeline has had a hole blown in it after a phase 3 trial of riliprubart in rare disease CIDP was stopped for futility.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.